Genomic aberrations in plasma cell leukemia shown by interphase fluorescence in situ hybridization
- 1 January 2005
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 156 (2), 150-153
- https://doi.org/10.1016/j.cancergencyto.2004.05.004
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Clinical and biologic implications of recurrent genomic aberrations in myelomaBlood, 2003
- Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapyBlood, 2002
- Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentationBlood, 2002
- Chromosome translocations in multiple myelomaOncogene, 2001
- Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridizationBlood, 2000
- Predictive Role of Interphase Cytogenetics for Survival of Patients With Multiple MyelomaJournal of Clinical Oncology, 2000
- High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridizationGenes, Chromosomes and Cancer, 1999
- Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridizationLeukemia, 1999
- Plasma cell leukemia: An evaluation of response to therapyAmerican Journal Of Medicine, 1987
- Plasma cell leukemia. Report on 17 casesArchives of Internal Medicine, 1974